Intravenous propofol in the treatment of refractory headache

Headache

Volumn 42, Issue 7, 2002, Pages 638-641

  Mendes, Paula M ^a   Silberstein, Stephen D ^a,b,c   Young, William B ^b   Rozen, Todd D ^d   Paolone, Mary F ^a,b  

^a JEFFERSON HEADACHE CENTER   (United States)

^b Deparmtent of Neurolgy   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d NONE

Author keywords

Anesthesia; Chronic daily headaches; Propofol; Refractory headaches; Sedation; Transformed migraine

Indexed keywords

PROPOFOL;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANESTHETICS, INTRAVENOUS; CHRONIC DISEASE; FEMALE; HEADACHE DISORDERS; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PAIN, INTRACTABLE; PROPOFOL; TREATMENT OUTCOME;

EID: 0036657342     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02151.x     Document Type: Article

References (6)

1. Classification of daily and near-daily headaches: Field trial of revised IHS criteria
2. Propofol: A highly effective treatment for acute headaches
3. Propofol increases agonist efficacy at the GABA-A receptor
4. The general anesthetic propofol slows deactivation and desensitization of GABA-A receptors
5. Effect of propofol on perception of pain in mice: Mechanisms of action. Part A. Molecular and integrative
6. Effects of propofol on isolated human omental arteries and veins